Standard usage and dosage guide for Mavakatai/Mefantal

Mavacamten (mavacamten) is a targeted drug for the treatment of hypertrophic cardiomyopathy (HCM). Its usage and dosage should be adjusted according to the individual conditions of the patient. The success of the treatment process is closely related to the precise control of drug dosage, therefore, it is very important to follow the recommended usage guidelines when using Marvaxet.

1. Starting dose: The recommended starting dose of Mavaceta is 5 mg each time, once a day, orally. This medication can be taken with food or on an empty stomach, but be sure to swallow the capsule whole and do not crush, chew, or open the capsule.

2. Dosage adjustment: According to the patient’s tolerance and clinical needs, the dose of Mavakatai can be adjusted according to the following principles. Common dosage adjustment ranges include 2.5 mg, 5 mg, 10 mg, or 15 mg taken orally once. During treatment, if the patient tolerates the drug well and the condition is under control, the dose can be gradually increased to the maximum dose of 15 mg, once a day.

3. Treatment of missed doses: If the patient misses a dose of Mavakatai, he should take it as soon as possible. However, if the missed dose exceeds 4 hours, he should skip the missed dose and continue taking the medicine at the regular time. Patients should avoid taking two doses on the same day to make up for a missed dose.

4. Treatment monitoring: During the treatment process, doctors need to regularly evaluate the patient's heart function, blood pressure and other related indicators to ensure the efficacy of the drug and adjust the dose in a timely manner. Patients should have regular blood tests to make sure the medication is not causing serious side effects.

In general, as an innovative drug for the treatment of hypertrophic cardiomyopathy, the standard usage and dosage of Mavaceta should strictly follow the doctor's recommendations and be personalized according to the patient's specific conditions.

Reference materials:https://bnf.nice.org.uk/drugs/mavacamten/